All In Biotech

Drug Trial Radar · NCT04089579

hCT-MSC in Children With Autism Spectrum Disorder

A Phase II Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder

Last checked: Nov 20, 2026Latest source record: Jun 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 137 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

137

Actual

Start

Oct 12, 2020

Primary completion

May 2, 2023

Study completion Feb 1, 2024

Sponsor

Lead sponsor
Joanne Kurtzberg, MDAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Marcus Foundation; Cryo-Cell International
First posted
Sep 13, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Phase II study is to determine the efficacy of human umbilical cord tissue-derived mesenchymal stromal cells (hCT-MSC) for improving social communication abilities in children with autism spectrum disorder (ASD).

Conditions

  • Autism
  • Autism Spectrum Disorder

Interventions

  • Cord Tissue Mesenchymal Stromal CellsBiological

    Human Umbilical Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC), isolated and expanded from umbilical cord tissue from allogeneic unrelated donors. One dose of 6x10e6 cells/kg administered intravenously.

  • Placebo InfusionOther

    Placebo comparative infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change on the Average Socialization and Communication Subscale Standard Scores on the Vineland Behavior Scales (VABS-3)Time frame: Baseline, 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Duke University Medical Center

    Durham, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.